Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ENvue Medical
From its filings with the US Securities and Exchange Commission
ENvue Medical is based in Tyler, Texas and is incorporated in Delaware. Its shares trade on OTC under the ticker FEED. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $2.6m and a net loss of $18.2m. At that date it held total assets of $41.1m and shareholders' equity of $33.5m.
Merger, the “Merger”), with Second Merger Sub being the surviving entity of the Second Merger (“Surviving Entity”).
Stock”) in excess of the Exchange Cap to the holders of Predecessor ENvue in consideration for 100% of Predecessor ENvue.
According to FDA guidelines, an adult is defined as a person who is 22 years of age or older.
Drive™, intended to automate aspects of electromagnetic navigation for enteral and vascular access procedures at the bedside.
Development timelines and commercialization remain subject to engineering progress and applicable regulatory approvals.
Quoted from its 10-K, filed 15 Apr 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 24 Apr 2015
- Employees
- 10
- Website
- nanovibronix.com ↗
- Head office
- 969 PRUITT AVE,, TYLER, TX, 77569
- Incorporated in
- DE
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Christopher FashekIndependent Chairman of the Board$185,178
- Dr. Doron BesserChief Executive Officer, Director, since 2025
- Mr. Stephen BrownChief Financial Officer$306,220
- Dr. Harold JacobChief Medical Officer, since 2003$20,543
- Mr. Brian MurphyDirector, since 2016$424,035
- Dr. Martin GoldsteinIndependent Director$35,299
- Mr. Thomas MikaIndependent Director$43,712
- Prof. Zeev RotsteinIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company has a focused product portfolio including PainShield, WoundShield, and UroShield.
- It operates in multiple regions including the United States, Europe, and India.
- It has a subsidiary in Israel for research and development activities.
Weaknesses
- The company employs only 10 full-time employees.
- It has a limited number of products under development such as Renooskin and Endotrachshield.
- Its website appears to be for a different company as it redirects to nanovibronix.com.
Opportunities
- The company could expand its product offerings with additional devices under development.
- There is potential for growth in the health care sector for noninvasive therapeutic devices.
- The company's focus on noninvasive treatments aligns with current medical trends.
Threats
- The company's website redirects to a different company's site, which may cause confusion.
- The company has a small employee base which could limit its operational capacity.
- The company's products are not widely known as it has limited marketing presence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.